文献速递骨质疏松与钙磷/甲状旁腺

维生素D结合球蛋白与生物可利用维生素D浓度和冠心病事件的关联:动脉粥样硬化多种族研究(MESA)

Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA).
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

在MESA研究中开展病例-队列分析,纳入12年随访期间发生冠心病事件的538例受试者和随机选取的999例亚队列受试者,采用质谱法测定基线25(OH)D、维生素D结合球蛋白(VDBG)及亚型,并依据已发表公式估算生物可利用25(OH)D。结果显示VDBG每增加1个标准差,冠心病风险增加(HR 1.77,95%CI 1.46–2.14,P<0.0001),且无种族或亚型异质性;低总25(OH)D与冠心病事件的关联因种族而异,校正VDBG后该异质性仍存在,生物可利用25(OH)D仅在白人受试者中与冠心病事件相关。

要点

  • VDBG浓度每增加1个标准差,冠心病事件风险增加(HR 1.77,95%CI 1.46–2.14,P<0.0001),各种族和亚型间无显著异质性。
  • 低总25(OH)D与冠心病事件的关联因种族而异,校正VDBG后交互作用P=0.05,异质性未被解释。
  • 生物可利用25(OH)D仅在白人受试者中与冠心病事件相关。

核心结论

  • 高VDBG浓度与所有种族和族裔群体的冠心病事件相关。
  • 纳入VDBG增强了25(OH)D与冠心病之间已有的关联,但并未解释25(OH)D与冠心病关联中的种族异质性。

研究设计与样本

  • 在动脉粥样硬化多种族研究(MESA)内开展的病例-队列研究。
  • 纳入12年随访期间发生冠心病事件的538例受试者和随机选取的999例亚队列受试者。
  • 采用质谱法测定基线25(OH)D、VDBG及亚型,并依据已发表公式估算生物可利用25(OH)D。

主要发现

  • VDBG每增加1个标准差,冠心病风险增加(HR 1.77,95%CI 1.46–2.14,P<0.0001),种族或亚型交互作用P均>0.1。
  • 低总25(OH)D与冠心病事件的关联因种族而异,未校正VDBG时交互作用P=0.04,校正VDBG后交互作用P=0.05。
  • 在白人或华裔受试者中,校正VDBG后25(OH)D与冠心病的关联增强。
  • 生物可利用25(OH)D仅在白人受试者中与冠心病事件相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Low 25-hydroxyvitamin D [25(OH)D] is associated with coronary heart disease (CHD) in people who are white and Chinese but not black or Hispanic. Vitamin D binding globulin (VDBG) avidly binds 25(OH)D, reducing its bioavailability, and differs in isoform and concentration by race. OBJECTIVE: Evaluate associations of VDBG with CHD and whether accounting for VDBG or estimating bioavailable 25(OH)D explains the heterogeneity of the association of 25(OH)D with CHD. DESIGN AND SETTING: We conducted a case-cohort study within the Multi-Ethnic Study of Atherosclerosis. Participants with an incident CHD event over 12 years of follow-up (n = 538) and a randomly assigned subcohort (n = 999) were included. We measured baseline 25(OH)D, VDBG, and isoforms using mass spectrometry and estimated bioavailable 25(OH)D from published equations. RESULTS: VDBG was associated with an increased risk of CHD [hazard ratio, 1.77 (95% confidence interval, 1.46 to 2.14) per standard deviation increment, P < 0.0001], without evidence of heterogeneity by race or isoform (each P for interaction > 0.1). Low total 25(OH)D was differentially associated with CHD events, by race, with or without adjustment for VDBG (P for interaction = 0.04 or 0.05, respectively). Associations of 25(OH)D with CHD were strengthened with adjustment for VDBG among participants who were white or Chinese, and bioavailable 25(OH)D was associated with CHD events only among white participants. CONCLUSIONS: High VDBG concentration was associated with CHD events in all racial and ethnic groups. Incorporation of VDBG strengthened existing associations of 25(OH)D with CHD but did not explain racial heterogeneity in associations of 25(OH)D with CHD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Robinson-Cohen C, Zelnick LR, Hoofnagle AN, et al. Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Endocrinol Metab. 2017. PMID: 28472285. doi:10.1210/jc.2017-00296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。